Leah Good

MD Media Inc (Canada) was founded by Richard Skaife and is currently led by CEO Connor Haslam. The Canadian company is dedicated to breaking down barriers and dispelling misconceptions surrounding psychedelic medicine. The company provides comprehensive news, insights, and educational content on scientific breakthroughs, industry developments, investment opportunities, and the cultural significance of psychedelics. MD Media Inc offers a range of services including public relations, custom content, digital advertising, storytelling, and event sponsorship, exhibition, and activations. The company aims to empower individuals, communities, and organizations to embrace the therapeutic potential of these transformative substances.

MD Media Inc (Canada) was founded by Richard Skaife and is currently led by CEO Connor Haslam. The Canadian company is dedicated to breaking down barriers and dispelling misconceptions surrounding psychedelic medicine. The company provides comprehensive news, insights, and educational content on scientific breakthroughs, industry developments, investment opportunities, and the cultural significance of psychedelics. MD Media Inc offers a range of services including public relations, custom content, digital advertising, storytelling, and event sponsorship, exhibition, and activations. The company aims to empower individuals, communities, and organizations to embrace the therapeutic potential of these transformative substances.

MD Media Inc (Canada) was founded by Richard Skaife and is currently led by CEO Connor Haslam. The Canadian company is dedicated to breaking down barriers and dispelling misconceptions surrounding psychedelic medicine. The company provides comprehensive news, insights, and educational content on scientific breakthroughs, industry developments, investment opportunities, and the cultural significance of psychedelics. MD Media Inc offers a range of services including public relations, custom content, digital advertising, storytelling, and event sponsorship, exhibition, and activations. The company aims to empower individuals, communities, and organizations to embrace the therapeutic potential of these transformative substances.